57 related articles for article (PubMed ID: 38642210)
1. Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.
Chen M; Zhang X; Xiong Y; Xu G
Int Urol Nephrol; 2023 Mar; 55(3):641-651. PubMed ID: 36161550
[TBL] [Abstract][Full Text] [Related]
2. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study.
Rui M; Jiang L; Pan JJ; Huang XT; Cui JF; Zhang SJ; He SM; Han HH; Chen X; Wang DD
Int Urol Nephrol; 2024 Apr; ():. PubMed ID: 38642210
[TBL] [Abstract][Full Text] [Related]
3. Combination of ultra-low dose rituximab and low dose tacrolimus versus tacrolimus alone in the treatment of non-responsive idiopathic membranous nephropathy: a Chinese retrospective cohort study.
Zhu F; Chu X; Guo Y; Li Y; Cao C; Wu J; Xu H; Deng X; Li J; Liu X; Yao Y; Zeng R
Am J Transl Res; 2021; 13(7):7622-7631. PubMed ID: 34377239
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy.
Peng L; Wei SY; Li LT; He YX; Li B
J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
6. Detection and clinical significance of glomerular M-type phospholipase A
Liu H; Luo W; Gong S; Ding X
Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
[TBL] [Abstract][Full Text] [Related]
7.
Kim DS; Park Y; Choi JW; Park SH; Cho ML; Kwok SK
Front Immunol; 2021; 12():696074. PubMed ID: 34956169
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials.
Huang H; Liang Z; Zheng X; Qing Q; Du X; Tang Z; Wei M; Wang C; Zhong Q; Lin X
Ren Fail; 2021 Dec; 43(1):840-850. PubMed ID: 34016023
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Time Course and Dose Effect From Metformin on Body Mass Index in Children and Adolescents.
Wang DD; Mao YZ; He SM; Chen X
Front Pharmacol; 2021; 12():611480. PubMed ID: 33981216
[TBL] [Abstract][Full Text] [Related]
10. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez G; Rojas-Rivera J; Logt AV; Justino J; Sevillano A; Caravaca-Fontán F; Ávila A; Rabasco C; Cabello V; Varela A; Díez M; Martín-Reyes G; Diezhandino MG; Quintana LF; Agraz I; Gómez-Martino JR; Cao M; Rodríguez-Moreno A; Rivas B; Galeano C; Bonet J; Romera A; Shabaka A; Plaisier E; Espinosa M; Egido J; Segarra A; Lambeau G; Ronco P; Wetzels J; Praga M;
Kidney Int; 2021 Apr; 99(4):986-998. PubMed ID: 33166580
[TBL] [Abstract][Full Text] [Related]
11. Analysis of time course and dose effect of tacrolimus on proteinuria in lupus nephritis patients.
Chen X; Wang DD; Li ZP
J Clin Pharm Ther; 2021 Feb; 46(1):106-113. PubMed ID: 32974902
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tacrolimus-based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study.
Zhang XJ; Ji CF; Yuan JZ; Wang L; Zhang J; Fang W; Bai DF; Hu Z
Kaohsiung J Med Sci; 2019 Oct; 35(10):633-639. PubMed ID: 31225949
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of pathological features of primary membranous nephropathy.
Zhang XD; Cui Z; Zhang MF; Wang J; Zhang YM; Qu Z; Wang X; Huang J; Wang F; Meng LQ; Cheng XY; Wang SX; Liu G; Zhao MH
BMC Nephrol; 2018 Aug; 19(1):215. PubMed ID: 30153817
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
